Clinical Trials · NCT01509755
Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 196
- Start date
- Oct 2000
- Locations
- 29 sites, 4 countries
- Primary endpoint
- HbA1c (glycosylated haemoglobin)